Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Navamedic appoints new CFO

Navamedic ASA
Posted on: 23 Aug 16

Oslo, 23 August 2016 - Navamedic ASA (OSE: NAVA), today announces the appointment of Toril Marie Ås as the new Chief Financial Officer of the company. Ms. Ås has been Navamedic's interim CFO since 1 February 2016.

"We are pleased to announce the appointment of Toril Marie Ås as our new CFO. With her extensive experience, Toril has been an invaluable addition to our company and management team, and we are looking forward to working together with Toril on a permanent basis," says Tom Rönnlund, Chief Executive Officer of Navamedic.

Ms. Ås holds a M.Sc. in Business from Bodø Graduate School of Business, and a M.Sc. in Management from London Business School. She has more than 20 years' executive experience from service-, telecom- and media organisations. Prior to joining Navamedic as interim CFO on 1 February 2016, ms. Ås held a position as CFO for Telenor Media Invest. Ms. Ås is a Norwegian citizen, and will be based at Navamedic's Oslo office.



For further information, please contact:

Tom Rönnlund, CEO, Navamedic. Telephone +46 727 320 321.


Navamedic ASA is a Norwegian medtech and pharmaceutical products company, delivering products to patients, hospitals and pharmacies in the Nordic and Benelux markets. The Group's Medtech business has developed and is currently introducing the next generation of digital urine meter Sippi®. Navamedic's Pharma and Healthcare business is a distributor of products supplied by a number of pharmaceutical manufacturers. Navamedic is listed on the Oslo Stock Exchange (ticker: NAVA).

 This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Navamedic ASA via GlobeNewswire

Last updated on: 24/08/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.